Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11):804–826

Article  CAS  PubMed  Google Scholar 

Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of Acromegaly and the impact of the Current Treatment Landscape: an update. Endocr Rev 40(1):268–332

Article  PubMed  Google Scholar 

Fleseriu M, Barkan A, Del Pilar Schneider M, Darhi Y, de Pierrefeu A, Ribeiro-Oliveira A Jr. et al (2022) Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2):296–307

Article  PubMed  PubMed Central  Google Scholar 

Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7–22

Article  CAS  PubMed  Google Scholar 

Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G et al (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003–1037

Article  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Christ-Crain M, Langlois F, Gadelha M, Melmed S (2024) Hypopituitarism. Lancet. May 9:S0140-6736(24)00342-8. doi: 10.1016/S0140-6736(24)00342-8

Yedinak C, Hameed N, Gassner M, Brzana J, McCartney S, Fleseriu M (2015) Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study. Pituitary 18(5):701–709

Article  PubMed  Google Scholar 

Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C et al (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab. ;105(4)

Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B et al (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667–678

Article  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M et al (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective. Pituitary 23(4):327–337

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Dekkers OM, Karavitaki N (2020) Endocrinology in the time of COVID-19: management of pituitary tumours. Eur J Endocrinol 183(1):G17–G23

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyerowitz EA, Scott J, Richterman A, Male V, Cevik M (2024) Clinical course and management of COVID-19 in the era of widespread population immunity. Nat Rev Microbiol 22(2):75–88

Article  CAS  PubMed  Google Scholar 

Tenforde MW, Link-Gelles R (2023) Reduction in COVID-19-related mortality over time but disparities across population subgroups. Lancet Public Health 8(5):e327–e8

Article  PubMed  PubMed Central  Google Scholar 

Omboni S, Padwal RS, Alessa T, Benczur B, Green BB, Hubbard I et al (2022) The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health 1:7–35

PubMed  PubMed Central  Google Scholar 

Crisafulli S, Luxi N, Sultana J, Fontana A, Spagnolo F, Giuffrida G et al (2021) Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol 185(2):251–263

Article  CAS  PubMed  Google Scholar 

Gatto F, Khorrami K, Nista F, Corica G, Ferone D (2021) Acromegaly Management in a Tertiary Referral Center after 1 year of the Coronavirus 2019 pandemic: a double challenge. Endocr Pract 27(8):856–857

Article  PubMed  PubMed Central  Google Scholar 

Demir AN, Sulu C, Kara Z, Sahin S, Ozaydin D, Sonmez O et al (2023) Changing presentation of acromegaly in half a century: a single-center experience. Pituitary 26(5):573–582

Article  PubMed  Google Scholar 

Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182(6):523–531

Article  CAS  PubMed  Google Scholar 

Siegel S, Streetz-van der Werf C, Schott JS, Nolte K, Karges W, Kreitschmann-Andermahr I (2013) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16(4):507–514

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention Background for CDC’s Updated Respiratory Virus Guidance [ https://www.cdc.gov/respiratory-viruses/background/index.html

Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1–13

Article  PubMed  Google Scholar 

Giustina A, Legg E, Cesana BM, Frara S, Mortini P, Fleseriu M (2021) Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era. Endocrine 71(2):273–280

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khawaja S, Marks M, Gurnell M, Fleseriu M ACROCOVID II: an international survey on acromegaly management more than 1 year into the COVID-19 pandemic era: The 2021 NORD Breakthrough Summit; 2021 [ https://rarediseases.org/the-2021-nord-breakthrough-summit/

Williams SP, Leong SC (2021) One year into the COVID-19 pandemic: what do we know so far from studies assessing risk and mitigation of droplet aerosolisation during endonasal surgery? A systematic review. Clin Otolaryngol 46(6):1368–1378

Article  PubMed  PubMed Central  Google Scholar 

Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A (2021) COVID-19 and the pituitary. Pituitary 24(3):465–481

Article  CAS  PubMed  PubMed Central  Google Scholar 

Penner F, Grottoli S, Lanotte MMR, Garbossa D, Zenga F (2021) Pituitary surgery during Covid-19: a first hand experience and evaluation. J Endocrinol Invest 44(3):635–636

Article  CAS  PubMed  Google Scholar 

Liu KQ, Dallas J, Wenger TA, Ristianto Z, Ding L, Chow F et al (2023) Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19. J Clin Neurosci 117:20–26

Article  PubMed  Google Scholar 

Aziz MF, Schenning K, Koike S, O’Glasser A, O’Reilly-Shah VN, Sera V et al (2024) Perioperative Mortality of the COVID-19 recovered patient compared to a Matched Control: a Multicenter Retrospective Cohort Study. Anesthesiology 140(2):195–206

Article  CAS  PubMed  Google Scholar 

SenthilKumar G, Verhagen NB, Nimmer K, Yang X, Figueroa Castro CE, Szabo A et al (2024) Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in patients with preoperative COVID-19 undergoing Cancer surgery. J Am Coll Surg

Yuen KCJ, Blevins LS Jr., Findling JW (2020) Important management considerations in patients with Pituitary disorders during the time of the Covid-19 pandemic. Endocr Pract 26(8):915–922

Article  PubMed  PubMed Central  Google Scholar 

United States Food and Drug Adminsrtation SOMATULINE® DEPOT (lanreotide) INJECTION Initial U.S. Approval: 2007 2014 [ https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022074s011lbl.pdf

Fleseriu M, Zhang Z, Hanman K, Haria K, Houchard A, Khawaja S et al (2023) A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly. Pituitary 26(1):9–41

Article  CAS  PubMed  Google Scholar 

Fleseriu M, Molitch M, Dreval A, Pokramovich Y, Bondar I, Poteshkin Y et al (2023) MPOWERED Trial Open-label extension: long-term efficacy and Safety data for oral Octreotide capsules in Acromegaly. J Clin Endocrinol Metab 108(12):3214–3222

Article  PubMed  PubMed Central  Google Scholar 

Gulletta S, Della Bella P, Pannone L, Falasconi G, Cianfanelli L, Altizio S et al (2022) QTc interval prolongation, inflammation, and mortality in patients with COVID-19. J Interv Card Electrophysiol 63(2):441–448

Article  PubMed  Google Scholar 

Varney JA, Dong VS, Tsao T, Sabir MS, Rivera AT, Ghula S et al (2022) COVID-19 and arrhythmia: an overview. J Cardiol 79(4):468–475

Article  PubMed  Google Scholar 

Fleseriu M (2021) Pituitary disorders and COVID-19, Reimagining Care: the pandemic A year and counting. Front Endocrinol (Lausanne) 12:656025

Article  PubMed  Google Scholar 

de Jesus Nunes R, Masullo LF, de Fonseca Lira MZR, Leite CMG, Gomes TM, Fontenele EGP et al (2022) Impact of the COVID-19 pandemic in the treatment of patients with acromegaly in a tertiary center: a wake-up call on the importance of telemedicine. Arch Endocrinol Metab 66(6):863–867

PubMed  Google Scholar 

Naves LA, Rosa IN, Lima TAS, Santana LB, Castro LF, Casulari LA (2021) Implementation and monitoring of a Telemedicine Model in Acromegalic outpatients in a low-income country during the COVID-19 pandemic. Telemed J E Health 27(8):905–914

Article  PubMed  Google Scholar 

Filippi E, Camerini S, Spinello M, Vettor R, Maffei P, Dassie F (2022) Impact of COVID-19 outbreak on acromegaly patients management. Endocr Abstracts 81:EP1201

Google Scholar 

Herman R, Janez A, Goricar K, Rizzo M, Jensterle M (2022) Impact of COVID-19 pandemic on Disease Control Status and Quality of Life of patients with Acromegaly. Med (Kaunas). ;58(12)

Pivonello R, Neggers S, Imran SA (2023) Psychopathology in Acromegaly-Real and Perceived. J Clin Endocrinol Metab 108(10):2470–2474

Article  PubMed  Google Scholar 

Pirchio Rosa SA, Renata C, Valeria G, Federico C, Giulia R, Marta et al (2022) Impact of COVID-19 lockdown in patients with acromegaly: an Italian multicenter experience. Endocr Abstracts 81:81P664

Google Scholar 

Durcan E, Turan S, Sahin S, Sulu C, Taze SS, Kavla Y et al (2021) Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease. Pituitary 24(4):589–599

Article  CAS